Cargando…
C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer.
This study tries to evaluate the associations between circulating C-reactive protein (CRP) and the overall survival of patients with non-small cell lung cancer (NSCLC). One hundred ninety-two patients with advanced NSCLC who treated with chemotherapy were enrolled in this study. The cut-off value of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616372/ https://www.ncbi.nlm.nih.gov/pubmed/31261584 http://dx.doi.org/10.1097/MD.0000000000016238 |